← Open Payments lookup

AUGUSTINA AGARUWA: Open Payments

NPI 1376119024 · CLINTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$442 in 17 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $287 · 2025 $442

Food & beverage: $442
CompanyPaymentsAmount
Axsome Therapeutics, Inc.1$105
Otsuka America Pharmaceutical, Inc.3$75
ABBVIE INC.3$64
Lundbeck LLC3$59
Neurocrine BioSciences, Inc.2$53
Otsuka Pharmaceutical Development & Commercialization, Inc.1$23
Supernus Pharmaceuticals, Inc.1$18
Vanda Pharmaceuticals Inc.1$16
E.R. Squibb & Sons, L.L.C.1$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: Auvelity, VRAYLAR, INGREZZA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, REXULTI, Qelbree, FANAPT.

Industry payments across MD — which companies pay providers there.